Willis Towers Watson Public : Form 8.3 -Willis Towers Watson Plc
July 29, 2020 at 08:07 pm IST
Share
TIDM0Y4Q TIDM0XHL
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in Willis Towers Watson plc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.000304635 ordinary shares
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 28(th) July 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- ------------------- -----------
Number (%) Number (%)
------------------------------------- --------- -------- ------ ---
(1) Relevant securities 5,489,735 4.26344%
------------------------------------- --------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- --------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- --------- -------- ------ ---
Total 5,489,735 4.26344%
------------------------------------- --------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 15 209.94
-------------- ----------------------------- -----------------------
Purchase 1,928 209.94
-------------- ----------------------------- -----------------------
Purchase 100 209.94
-------------- ----------------------------- -----------------------
Purchase 200 209.94
-------------- ----------------------------- -----------------------
Purchase 2,496 209.94
-------------- ----------------------------- -----------------------
Purchase 870 209.94
-------------- ----------------------------- -----------------------
Purchase 27 209.94
-------------- ----------------------------- -----------------------
Purchase 63 209.94
-------------- ----------------------------- -----------------------
Purchase 18 209.94
-------------- ----------------------------- -----------------------
Sale 234 210.33
-------------- ----------------------------- -----------------------
Sale 5,500 210.51
-------------- ----------------------------- -----------------------
Sale 100 209.94
-------------- ----------------------------- -----------------------
Sale 705 209.94
-------------- ----------------------------- -----------------------
Sale 200 209.94
-------------- ----------------------------- -----------------------
Sale 45 209.94
-------------- ----------------------------- -----------------------
Sale 151 209.94
-------------- ----------------------------- -----------------------
Sale 350 210.33
-------------- ----------------------------- -----------------------
Sale 333 210.33
-------------- ----------------------------- -----------------------
Sale 621 210.33
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- ----------------
Date of disclosure 29(th) July 2020
------------------------------------------------------- ----------------
Contact name Lionel Colaco
------------------------------------------------------- ----------------
Telephone number 020 33956098
------------------------------------------------------- ----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- ----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- ----------------
Willis Towers Watson Public Limited Company is a world leader in consulting, insurance brokerage and risk management software development. Revenues break down by activity as follows:
- human capital and social benefits consulting services (35.6%): consulting services in the organization, skills assessment, management and optimization of social benefits, compensation of executives and employees, etc. ;
- development of enterprise risk management solutions and services (31.9%): risk analysis, assessment consulting, effective risk management and anticipation services, design and development of software solutions for risk management. The group is also developing an insurance brokerage activity;
- risk/return balance management consulting services (17.7%): for investors, insurers and reinsurers. Additionally, the group offers insurance and reinsurance consulting services, financial management services, financing and investment strategies, as well as actuarial studies and expertise in mergers and acquisitions, etc., while developing software solutions for modeling and analysis of risks and financial activities;
- management and operation of a platform for the exchange and outsourcing of group health insurance plans and medical benefits (14.7%): allowing employees and retirees to choose the health coverage that meets their needs;
- other (0.1%).
Revenue is distributed geographically as follows: Ireland (1.7%), the United States (49.7%), the United Kingdom (20.5%) and other (28.1%).